🔎 Trials Near Me

Nyumbani › Vimeng'enya vya Ubongo

Majaribio ya kliniki ya Vimeng'enya vya Ubongo yanayovutia washiriki nchini Marekani

Masomo 197 ya Vimeng'enya vya Ubongo yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06991101

Tumor Related Epilepsy

InaajiriUtafiti wa uchunguzi
Umri 8 hadi 99 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT02639325

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT05222620

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

InaajiriHatua 1
Umri 21 hadi 70 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06815432

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

InaajiriHatua 1/2
6 Months – 25 Years · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT04085887

Evaluation and Treatment of Neurosurgical Disorders

InaajiriUtafiti wa uchunguzi
Umri 4 hadi 99 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT00060541

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07326566

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

InaajiriHatua 1/2
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07416188

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT04923542

C-SMART vs BE Well for Patients With Brain Tumors

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07224503

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06047379

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

InaajiriHatua 1
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT06389591

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT05733312

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07248228

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07470606

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07831772

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT04977375

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

InaajiriHatua ya kwanza ya awali
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06055790

PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe

InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07827001

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07053033

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07227610

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT05048212

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT05786924

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.